Pharmaceutical Benefits Regulations (Amendment) (Cth)

STATUTORY RULES.

1952. No..

REGULATIONS UNDER THE PHARMACEUTICAL BENEFITS ACT 1947-1950.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Pharmaceutical Benefits Act 1947-1950.

Dated this first day of April, 1952.

Governor-General.

By His Excellency’s Command,

SGD. EARLE PAGE

Minister of State for Health.

Amendments of the Pharmaceutical Benefits Regulations. 

Second Schedule.

1. The Second Schedule to the Pharmaceutical Benefits Regulations is amended—

(a) by omitting item 1 and inserting in its stead the following item:—

“1	Acetarsol.....................................	2 cc. amp..................	10	1
Soluble..........................................	3 cc. amp..................	10	1”;

(b) by omitting item 4 and inserting in its stead the following item:—

“4	Adrenalin Tartrate	1 in 1,000....................	1 cc. amp................	6	1
1 in 1,000....................	10 cc. amp..............	1	1
1 in 1,000....................	25 cc. bottle............	1	..
1 in 1,000....................	1 fl. oz. bottle..........	1	..
1 in 1,000....................	30 cc. vial...............	1
1 in 100....................	7 cc. vial.................	1	1”;

(c) by omitting item 11 and inserting in its stead the following item:—

“11	Aureomycin.....................................	50 mg. cap. ..	25	3
250 mg. cap. ..	16	..
100 mg. cap. ..	6	1”;

(d) by omitting item 44 and inserting in its stead the following item:—

“44 Diphtheria Prophylactic (Alum Precipitated Toxoid) ............................. 3 cc. vial .. 1 1”;

   

* Notified in the Commonwealth Gazette on  , 1952.

  Statutory Rules 1950, No. 48, as amended by Statutory Rules 1950, Nos. 51, 55, 62 and 94; and 1951, Nos. 15, 89 and 135.

1251—Price 3d. 9/24.3.1952.

(e) by omitting items 58 and 64;

(f) by omitting item 65 and inserting in its stead the following item:—

“65	Heparin..............	1,000 U. per cc.	5 cc. vial.................	5	..
5,000 U. per cc.	5 cc. vial.................	1	..
25,000 U. per cc.	3 cc. vial.................	1	.. ”;

(g) by omitting item 68;

(h) by omitting item 79 and inserting in its stead the following item:—

 

“79	Isoprenaline Sulphate	..................	20 mg. tab.................	25	3
..................		10 cc. vial.................	1	..
10 mg. per cc.	7 cc. vial...................	1	1”;

(i) by omitting items 84 and 85;

(j) by omitting item 99 and inserting in its stead the following item:—

“99	Morphine with Atropine (E)	..................	1 hypo. tab................	20	..
Morphine Sulphate	..................	1 amp.......................	6	..
1/6 gr.....................	per cc........	10 cc. vial.................	1	..”;
Atropine Sulphate 1/150 gr...........................

(k) by omitting item 120;

(l) by omitting item 122 and inserting in its stead the following item:—

“122	Pethidine Hydro-chloride	50 mg. per cc.	1 cc. amp..................	6	..
50 mg. per cc.	2 cc. amp..................	6	..
50 mg. per cc.	25 cc. bottle..............	1	..
50 mg. per cc.	50 cc. bottle..............	1	..
..................	25 mg. tab.................	25	..
..................	50 mg. tab.................	25	..”;

(m) by omitting item 124b and inserting in its stead the following item:—

“124b	Phenobarbitone ..	3.1 gr. per 5 cc.	5 cc. amp..................	6	..
3 gr. per cc.	1 cc. amp..................	6	..
3 gr. per 1.5 cc.	1.5 cc. amp...............	6	..”;

(n) by omitting item 131a and inserting in its stead the following item:—

 

“131a	Procaine Penicillin (Aqueous)	..................	300,000 U. vial.........	6	..
400,000 U. per cc.		10 cc, vial.................	1	..
..................	900,000 U. vial.........	8	..
..................	3,000,000 U. vial.......	6	..”;

 

(o) by omitting item 132 and inserting in its stead the following item:—

 

“132	Procaine Pencillin (Crystalline)...........	................	300.000 U. amp.......	6	..
................		400,000 U. amp.......	6	..
................	500,000 U. amp.......	6	..
................	600,000 U. amp.......	6	..
................	667,000 U. amp.......	6	..
................	900,000 U. amp.......	6	..
................	1,200,000 U. amp.....	6	..
................	1,500,000 U. amp.....	6	..
................	2,000,000 U. amp.....	6	..
................	3,000,000 U. amp.....	6	..”;

(p) by omitting item 133 and inserting in its stead the following items:—

 

“133	PROCAINE PENICILLIN (oily)	300,000 U. per cc.	1cc. amp..................	6	..
300,000 U. per cc.		10cc. amp................	1	..
400,000 U. per cc.	10cc. amp................	1	..
600,000 U. amp.......	6	..
1 million U. amp......	6	..”;

(q) by inserting after item 168 the following item:—

“16.8aa	Terramycin..............	................	50 mg. cap...............	25	3
................	100 mg. cap.............	25	3
................	250 mg. cap.............	16	3
250 mg. per 10 cc.	10 cc. vial................	6	1”;

and

(r) by omitting item 172.

Amendments not to apply in certain cases.

2. Notwithstanding the amendments of the Pharmaceutical Benefits Regulations effected by the last preceding regulation, the provisions of the Pharmaceutical Benefits Regulations, as in force immediately before the date of commencement of these Regulations, shall continue to apply in relation to the supply of pharmaceutical benefits upon presentation, whether before or after that date, of prescriptions written before that date.

By Authority: L. F. Johnston, Commonwealth Government Printer, Canberra.